In an era of groundbreaking cell and gene therapies (CGT), reproducible data isn't just good practice – it's essential. From basic research to advanced clinical development, consistent data drives success. That’s why Miltenyi Biotec has engineered a comprehensive standardization concept for flow cytometric analysis that reins in variability from the ground up. As a result, outcomes are reproducible across experiments and research sites. Achieving that data consistency and comparability is the first step to efficiently scaling up studies, whether by increasing throughput or expanding to multiple sites.
Elements that eliminate variability and help generate reliable results include consistent reagents, workflow automation, and well-defined protocols. Thus, our standardization concept is built on three pillars: unwavering antibody quality, workflow-automating instruments, and intuitive, compliance-ready software.
The following chapters detail how those three pillars transform flow cytometry outcomes through true standardization.